4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002406
Chief Business & Legal Officer sold 3,155 shares at $15.17 ($47,861)
- Chief Business & Legal Officer acquired 28,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nickson Philip · Chief Business & Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form | +28,000 | 64,000 | D | ||
| 2026-01-05 | Sale : show line 2 in the form | −3,155 | $15.17 | $47,861 | 60,845 | D |
| Open-market sales · 3,155 sh · avg $15.17 · $47,861 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +126,000 | 126,000 | D |
Loading xslF345X05/ownership.xml…